Related references
Note: Only part of the references are listed.Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
Chiara Riganti et al.
PLOS ONE (2013)
Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside
Barbara Castella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells
Joanna Kopecka et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells
Joanna Kopecka et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between Vγ9Vδ2 T Cells, αβ CD8+ T Cells, Regulatory T Cells, and Dendritic Cells
Barbara Castella et al.
JOURNAL OF IMMUNOLOGY (2011)
Immune parameters affecting the efficacy of chemotherapeutic regimens
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Human γδ T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement
Amudhan Maniar et al.
BLOOD (2010)
IL-2 Costimulation Enables Statin-Mediated Activation of Human NK Cells, Preferentially through a Mechanism Involving CD56+ Dendritic Cells
Georg Gruenbacher et al.
CANCER RESEARCH (2010)
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Marc Bonneville et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma
Chiara Riganti et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Share Paper
